Trial
NCT00788580
S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
SWOG Cancer Research Network
Collaborators
National Cancer Institute (NCI)
Condition
Unspecified Adult Solid Tumor, Protocol Specific
Intervention
pazopanib hydrochloride
Why stopped
Study was discontinued.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-06